Abstract OT3-15-01: TBCRC-053: P-RAD: A Randomized Study of Preoperative Chemotherapy, Pembrolizumab and No, Low or High Dose RADiation in Node-Positive, HER2-Negative Breast CancerJoseph J. Connolly, Alice Ho, Elizabeth A. Mittendorf et al.|Cancer Research|2023Cited by 5
Abstract OT2-09-01: TBCRC-055: A Phase II Study of NirAparib, Dostarlimab, and Radiotherapy in Metastatic, PD-L1 Negative or Immunotherapy-Refractory Triple-Negative Breast Cancer (NADiR) – NCT04837209Elizabeth Scott, Alice Ho, Steven J. Isakoff et al.|Cancer Research|2023Cited by 3
Validation of Patient-Reported Outcomes in Patients With Nonmetastatic Breast Cancer Receiving Comprehensive Nodal Irradiation in the RadComp TrialElizabeth A. Hahn, Harald Paganetti, Stephanie L. Pugh et al.|International Journal of Radiation Oncology*Biology*Physics|2024Cited by 3